Evaluation of the Prevention and Treatment Effects of Chinese Medicine on High Altitude Illness

Learn more about:
Related Clinical Trial
Colorado-Oregon Altitude Study The Effects of Intermittent Hypoxia on Acute Hypoxic Injury Effect of Isocaloric Ketogenic Diet on Physical Performance at High Altitude The Pre-acclimatization Augmented Extreme Altitude Expedition Effect of Altitude on Iron Absorption in Iron Depleted Women Optimization Strategy for the Prevention of AMS by RIPC Combined With Acetazolamide Safety and Efficacy of T89 in the Prevention and Treatment of Adults With Acute Mountain Sickness (AMS) Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders With COPD Traveling to High Altitude Acetazolamide to Prevent Impending Altitude-illness in Patients With COPD HIGH Altitude CArdiovascular REsearch Latin America Population Study Effect of Acetazolamide on Sleep Disordered Breathing in Lowlanders Older Than 40 Years at Altitude Effects of Melatonin on Sleep, Ventilatory Control and Cognition at Altitude. Effect of Acetazolamide on Lung Water Content by Ultrasound in Lowlanders Older Than 40 Years at Altitude Effect of Acetazolamide on Right Heart Function During Exercise in Lowlanders Older Than 40 Years at Altitude Effect of Acetazolamide on Visuo-motor Learning in Lowlanders Older Than 40 Years at Altitude Effect of Acetazolamide on Maximal Exercise Performance in Lowlanders Older Than 40 Years at Altitude Physiological Adaptations to Simulated Intermittent Altitude on Human Health and Performance Iron Status and Cardiopulmonary Physiology Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders Older Than 40 Years at Altitude. Effect of Acetazolamide on Postural Control in Lowlanders Older Than 40 Years at Altitude Monitoring of the Cerebral Tissue Oxygenation and Perfusion in the Adapting Climber During Sleep in High Altitude The Psychophysiological Effect of Simulated and Terrestrial Altitude Relationship Between Succinate Dehydrogenase Mutations and High-Altitude Illness Cardio-respiratory Responses During Hypoxic Exercise in Individuals Born Prematurely Gut-microbiota Targeted Nutritional Intervention for Gut Barrier Integrity at High Altitude AZ, MZ, and the Pulmonary System Response to Hypoxia Study of the Effects of Iron Levels on the Lungs at High Altitude Effects of Aircraft Cabin Altitude on Passenger Comfort and Discomfort Three New Ideas to Protect Special Forces From the Stress of High Altitude Breathing Training to Improve Human Performance at High Altitude Oxidative Stress in Hypobaric Hypoxia Safety Evaluation of Aminophylline and Methazolamide Decompression Tables for Diving at Altitude Chronic Mountain Sickness, Systemic Vascular Function Evaluation of the Prevention and Treatment Effects of Chinese Medicine on High Altitude Illness Inhaled Budesonide for Altitude Illness Prevention Sickness Evaluation at Altitude With Acetazolamide at Relative Doses Prevention of Altitude Illness With Non-steroidal Anti-inflammatory Study (PAINS) Spectroscopic and Diffusion Weighted Analysis of the Effects of Dexamethasone on High Altitude Cerebral Oedema (HACE) Drug Combination on Exercise Performance at High Altitude Acclimatization Mechanisms During Ascent to 7500m Prevention of Acute Mountain Sickness by Intermittent Hypoxia Sickness Evaluation at Altitude With Acetazolamide at Relative Dosages Study Looking at End Expiratory Pressure for Altitude Illness Decrease (SLEEP-AID) Can Rhodiola Crenulata Intake Improve Oxygen Saturation and Decrease the Incidence of Acute Mountain Sickness Comparison of Metoclopramide and Ibuprofen for the Treatment of Acute Mountain Sickness A Trial of Acetazolamide Versus Placebo in Preventing Mountain Sickness During Rapid Ascent Training in Hypoxia to Prevent Acute Mountain Sickness Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness Altitude Sickness Prevention With Ibuprofen Relative to Acetazolamide and Treatment Efficacy Controlled Hyperventilation as Prophylaxis for Acute Mountain Sickness Inhaled Budesonide and Acute Mountain Sickness Altitude Sickness Prevention and Efficacy of Comparative Treatments Alternative Treatments in Acute Mountain Sickness Effect of Acetazolamide on Acute Mountain Sickness in Lowlanders Older Than 40 Years Safety and Efficacy of T89 in Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)

Brief Title

Evaluation of the Prevention and Treatment Effects of Chinese Medicine on High Altitude Illness

Official Title

Evaluation of the Prevention and Treatment Effects of Chinese Medicine on High Altitude Illness

Brief Summary

      This trial is aimed to evaluate the effects of "Wu Zhu Yu Tang" on the prevention of Acute
      Mountain Sickness(AMS).
    

Detailed Description

      This study is a randomized, double blind, placebo-controlled clinical trial. It aims to
      demonstrate that (1) Chinese medicine prescription "Wu Zhu Yu Tang" can prevent Acute
      Mountain Sickness(AMS) (2) "Wu Zhu Yu Tang" can prevent AMS especially for Yang-Xu body
      constitution.

      We will randomize 240 unacclimatized healthy adults. They will be randomized after
      stratification of the Yang-Xu score and the AMS history to receive Chinese medicine during
      one ascent and placebo during the other ascent. We will take them in Hehuan mountain for two
      days hike (24 hours) and an overnight over 3,000m. One month before the study, the subjects
      will fill the "Body Constitution Questionnaire BCQ" in order to evaluate their body
      constitution. Before, during and after the two days hike we will measure their blood
      pressure, heart rate and arterial oxygen saturation. The incidence of AMS will be measured by
      the Lake Louise Self Report (Lake Louise Score ≥4 with headache), we will also report the
      Lake Louise Clinical Assessment score and Lake Louise Functional Score.
    

Study Phase

Phase 2

Study Type

Interventional


Primary Outcome

The incidence of AMS will be measured by the Lake Louise Self Report (Lake Louise Score ≥4 with headache)

Secondary Outcome

 Blood pressure

Condition

Acute Mountain Sickness (AMS)

Intervention

Chinese Medicine

Study Arms / Comparison Groups

 Chinese Medicine
Description:  The participators in this arm will take 2g (powder in capsule) of "Wu Zhu Yu Tang" or placebo orally three times in the first day and one time in the second day.

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information


Recruitment Status

Drug

Estimated Enrollment

240

Start Date

September 2012

Completion Date

September 2012

Primary Completion Date

September 2012

Eligibility Criteria

        Inclusion Criteria:

          -  Healthy adults

        Exclusion Criteria:

          -  Chronic disease: cardiovascular disease, psychological disease, anemia, migraine.

          -  long-term use of the following materials: Chinese herbs, steroid, antibiotics.

          -  altitude acclimation: have been to mountain over 2000m in the past 1 month.

          -  Pregnancy.
      

Gender

All

Ages

20 Years - 70 Years

Accepts Healthy Volunteers

Accepts Healthy Volunteers

Contacts

, , 

Location Countries

Taiwan

Location Countries

Taiwan

Administrative Informations


NCT ID

NCT01682551

Organization ID

NRICM-10101


Responsible Party

Sponsor

Study Sponsor

China Medical University Hospital

Collaborators

 China Medical University, China

Study Sponsor

, , 


Verification Date

September 2012